Crossmark

What is the best clinical pathological score to identify high-risk patients with lobular carcinoma of the breast who are likely to benefit from adjuvant chemotherapy?

Crossref DOI link: https://doi.org/10.1007/s10549-019-05275-z

Published Online: 2019-05-22

Published Print: 2019-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Maltoni, Roberta

Bravaccini, Sara https://orcid.org/0000-0002-0075-8538
License Information

Text and Data Mining valid from 2019-05-22

Version of Record valid from 2019-05-22
More Information

Article History

Received: 24 April 2019

Accepted: 6 May 2019

First Online: 22 May 2019

Compliance with ethical standards

:

: We have no conflicts of interest to declare.

: The manuscript complies with the ethical rules applicable for this journal.

Document is current

Any future updates will be listed below